Detalhe da pesquisa
1.
Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma.
CA Cancer J Clin
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38571300
2.
2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race.
Cancer
; 130(3): 453-466, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37803521
3.
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.
Cancer
; 130(9): 1642-1649, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180804
4.
Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology.
CA Cancer J Clin
; 67(5): 362-377, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28731537
5.
Race-free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollment.
Cancer
; 129(6): 920-924, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606692
6.
Clinical and Economic Outcomes in Patients With Metastatic Urothelial Carcinoma Receiving First-Line Systemic Treatment (the IMPACT UC I Study).
Oncologist
; 28(9): 790-798, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432283
7.
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
Oncologist
; 28(12): e1219-e1229, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540787
8.
Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.
Oncologist
; 28(12): 1055-1063, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418599
9.
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
BMC Cancer
; 23(1): 265, 2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949413
10.
Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Cancer
; 128(11): 2073-2084, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285950
11.
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Cancer
; 128(6): 1194-1205, 2022 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882781
12.
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
Lancet
; 397(10288): 1895-1904, 2021 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33971152
13.
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.
Oncologist
; 27(3): 220-227, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274720
14.
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
Oncologist
; 27(10): e815-e818, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036607
15.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
; 130(5): 592-603, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597472
16.
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
Cancer
; 127(6): 840-849, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216356
17.
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Lancet
; 395(10241): 1907-1918, 2020 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473681
18.
Retrospective Study of Bleeding Risk with Concomitant Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor and Anticoagulation.
Oncologist
; 26(11): e2061-e2069, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34227189
19.
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
BJU Int
; 128(2): 196-205, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33556233
20.
PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer.
Future Oncol
; 17(2): 137-149, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32938232